https://pipelinereview.com/Centus-Biotherapeutics-Receives-European-Marketing-Authorization-for-Equidacent-Biosimilar-Avastin/
Centus Biotherapeutics Receives European Marketing Authorization for Equidacent, Biosimilar Avastin